Last, Laminar

Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/ 3 Clinical Trial of idroxioleic acid in combination with RT and TMZ for adults with newly diagnosed glioblastoma

Published on 08/07/2025 at 18:00 | prnewswire.co.uk

Laminar Pharmaceuticals, S.A. Spain

View original content:https://www.prnewswire.co.uk/news-releases/last-patient-in-laminar-pharmaceuticals-sa-completes-recruitment-for-clinglio-the-phase-2b3-clinical-trial-of-idroxioleic-acid-lam561-in-combination-with-rt-and-tmz-for-adults-with-newly-diagnosed-glioblastoma-302169695.html

en | boerse | 68019385 |